Brachytherapy for Cervical Cancer: How Internal Radiation Sessions Are Delivered

The radiation oncologist has finished drawing on the paper, and the picture looks like a pear with a thin rod running through it and two small circles beneath. Then comes the sentence that stops most people: ‘For the last part, we place the radiation inside.’ The woman across the desk nods, writes nothing down, and asks the only question that matters in that moment: ‘Will I be awake?’

Almost everyone treated for cervical cancer that has grown beyond its earliest stage will hear some version of that conversation. External radiation and chemotherapy fill the first several weeks and feel familiar enough; a machine, a table, a few minutes a day. Brachytherapy is different in texture. It involves an applicator, an anesthetist, a planning room full of physicists, and long stretches of lying still.

This explainer walks through brachytherapy for cervical cancer, what to expect at each step, what tends to hurt and what does not, how many visits are typical, and which side effects deserve a phone call rather than patience.

Brachytherapy for cervical cancer: what to expect in plain language

Brachytherapy is radiation delivered from a sealed source placed inside the body, right against the tumor; the name comes from the Greek word for ‘short,’ because the radiation only has to travel a very short distance. For cervical cancer it almost always comes after several weeks of external beam radiation, the kind delivered by a machine from outside the body, usually given alongside weekly chemotherapy. Together the two are called chemoradiation, and brachytherapy is the final, most concentrated part of that plan.

The honest one-paragraph version of what happens runs like this: a short procedure under anesthesia or sedation to place a hollow applicator, an hour or more of imaging and computer planning, a treatment that lasts minutes, then removal of the applicator, repeated a handful of times over roughly one to two weeks. The National Cancer Institute lists this combination of external radiation, chemotherapy and internal radiation as standard care for cervical cancer that has grown beyond the earliest stages but has not spread to distant organs.

What makes the internal step worth the effort is geometry. Radiation from a source inside the cervix falls off steeply with distance, so the tumor receives far more than the bladder in front of it and the rectum behind it. External beam alone cannot achieve that ratio safely, no matter how modern the machine. This is why radiation oncologists treat brachytherapy as an essential component rather than an optional extra, and why the whole schedule is arranged around fitting it in without long gaps.

One more piece of orientation helps. There are two broad ways to position the source. Intracavitary brachytherapy places the applicator in natural spaces, the uterine canal and the vagina. Interstitial brachytherapy adds thin hollow needles pushed directly into tissue when the tumor is too large or too lopsided for cavity applicators to cover. Your team chooses between them based on your scans, and sometimes combines both.

How internal radiation for cervical cancer actually works

Think of a bare lightbulb in a dark room. Stand an arm’s length away and the page in your hand is bright; step back to the far wall and you can barely read. Radiation from a small source behaves the same way. Intensity drops roughly with the square of the distance, so doubling the gap cuts exposure to about a quarter. Placing the source inside the cervix puts the tumor at ‘arm’s length’ and the bowel and bladder at the ‘far wall.’

The source itself is a tiny pellet of a radioactive isotope, most commonly iridium-192 in modern high-dose-rate systems, sealed at the tip of a thin cable. It lives in a lead-shielded machine called a remote afterloader. Once the applicator is in place and the plan is approved, staff leave the room, the afterloader threads the source out through the hollow channels of the applicator, and the source pauses at pre-calculated positions, called dwell positions, for pre-calculated seconds. When the sequence ends, the cable retracts and the source returns to its shield. Nothing radioactive remains in your body.

At the cellular level, radiation breaks strands of DNA. Cancer cells, dividing quickly and often with faulty repair machinery, struggle to fix that damage and die over the following days and weeks. Healthy tissue repairs more efficiently, which is one reason treatment is spread over several sessions rather than given all at once. Chemotherapy given during the external phase makes tumor cells more sensitive to radiation, a process described in the National Cancer Institute’s treatment summary.

The two forms of radiation divide the work. External beam treats the whole pelvis, including lymph nodes where cells may have traveled. Brachytherapy then delivers a boost to the primary tumor and the cervix that external beam could not deliver without harming the organs around it. Neither alone does the job that both do together, which is why guidelines pair them.

Who is usually offered brachytherapy, and who is asked to wait

Brachytherapy belongs mainly to women with locally advanced cervical cancer: tumors that are larger, have grown into nearby tissue such as the upper vagina or the tissue beside the uterus, or have reached pelvic lymph nodes, but have not spread to distant organs. For this group the National Cancer Institute and NHS both describe chemoradiation followed by brachytherapy as the standard approach, because the tumor is too extensive for surgery to remove cleanly and the pelvis needs treating as a whole.

It is less often used at the two ends of the spectrum. Very small, early tumors are usually treated with surgery, from a cone biopsy through to a radical hysterectomy, and radiation enters the picture only if the pathology report shows features that raise the risk of recurrence. After a hysterectomy, a shorter form of brachytherapy delivered to the top of the vagina, the vaginal cuff, may be recommended. At the other end, when cancer has spread to distant organs, systemic treatment takes priority and radiation is used mainly to control symptoms such as bleeding.

Being ‘asked to wait’ rarely means brachytherapy is off the table. Common reasons for a pause include an active pelvic infection that needs treating first, anemia severe enough to affect both anesthesia safety and how well radiation works, uncontrolled bleeding that needs stabilizing, or medical conditions that make anesthesia risky until they are optimized. Occasionally the anatomy simply does not allow a standard applicator: a narrow or scarred vagina, a uterus that cannot be safely sounded, or a tumor that has destroyed the cervical canal. In those cases the team may switch to interstitial needles, use a smaller applicator, or, rarely, substitute an external beam boost while acknowledging it is not equivalent.

Every one of these judgments sits with the treating team, who weigh your scans, blood counts, general health and the timeline of the external phase already under way.

What happens on the day: from arrival to applicator placement

Treatment days start early and unfold in a fixed order. You will usually be asked not to eat for several hours beforehand because of the anesthesia, and some units ask for a light bowel preparation so the rectum is empty on the planning scan. After checking in, a nurse places an intravenous line, reviews your medications and confirms you have someone to take you home if the plan is same-day discharge.

Placement happens in a procedure room or operating theater. Depending on the unit and your health, you may have a general anesthetic, a spinal anesthetic that numbs you from the waist down, or conscious sedation with local numbing. A urinary catheter is inserted so the bladder can be emptied and, on imaging, seen clearly. The radiation oncologist examines the cervix, gently measures the length of the uterine cavity with a thin probe, and then places the applicator.

For intracavitary treatment that applicator has two parts. The tandem is a slim hollow tube that passes through the cervix into the uterus. The ovoids or ring sit in the vagina against the cervix on either side. Some teams place a short hollow sleeve, sometimes called a Smit sleeve, in the cervical canal at the first session so later insertions are easier. If the tumor extends sideways, hollow needles may be added through a template resting against the vaginal opening. Everything is then held steady with gauze packing, which also pushes the bladder and rectum a little further from the source, and secured with a clamp or stitch.

From here you move, still lying flat, to imaging. Cleveland Clinic describes this sequence, placement followed by imaging and planning, as the normal rhythm of a high-dose-rate session, and it explains why the day runs to several hours even though the radiation itself is measured in minutes.

Is brachytherapy painful? Anesthesia, comfort and what patients describe

The radiation itself is completely painless; you cannot feel it any more than you feel a chest X-ray. What people are really asking about is the applicator, and here the answer depends on the phase of the day.

Placement is done under anesthesia or sedation, so the insertion is not felt. The waking hours afterward, while the applicator stays in, are where discomfort concentrates. Most women describe pressure and deep cramping similar to strong period pain, a feeling of fullness in the vagina and rectum from the packing, and an urge to pass urine caused by the catheter. Lying flat for several hours brings its own aches in the back and hips. Units manage this with pain relief prescribed by the anesthesia team, and you should ask for more if the first dose does not settle you; there is no advantage in being stoic.

Applicator removal, once the source has retracted, takes a minute or two. Many women describe it as a brief, sharp tug followed by immediate relief. Spotting and mild cramping for a day or two afterward are expected, as the Mayo Clinic’s overview of brachytherapy notes.

Two things shape the experience more than anything else. The first is anesthesia choice. Spinal anesthesia can keep the pelvis numb well into the planning phase; general anesthesia wears off sooner but avoids a needle in the back. The second is preparation. Knowing that you will be alone in a shielded room for a few minutes, watched on camera and able to speak through an intercom, removes a surprising amount of dread. Women who have had one session almost universally say the second is easier, not because it hurts less but because the unknown has gone.

Imaging and planning: why you wait between placement and treatment

The gap between applicator placement and the moment the source moves is the least understood part of the day, and the most important. Modern cervical brachytherapy is image-guided, which means the plan is built fresh around the position of the applicator and the shape of the tumor on that specific day, rather than from a standard template.

After placement you are scanned with the applicator in place, by CT, MRI or both. MRI shows the soft tissue of the cervix and any remaining tumor in far more detail than CT, so many centers use it at least for the first session. The radiation oncologist then outlines, slice by slice, the target that must receive full treatment and the organs that must be protected: bladder, rectum, sigmoid colon and small bowel. That outlining takes time, often the better part of an hour.

A medical physicist and dosimetrist then design the plan. Software calculates how long the source should pause at each dwell position along the tandem, ring and any needles so that the target is covered while the organs at risk stay under safety limits. The plan is checked independently, the applicator connection is verified, and only then are you moved into the shielded treatment room. Cleveland Clinic’s brachytherapy page describes this planning step as the reason each appointment stretches across several hours.

Why not skip it and reuse the previous plan? Because tumors shrink during treatment, the applicator never sits in exactly the same spot twice, and a full bladder or a loop of bowel can drift into the high-dose region. Re-planning each time is what allows the very high concentration of radiation that makes brachytherapy effective while keeping serious bowel and bladder injury uncommon. The wait is not dead time; it is the safety margin.

How many brachytherapy sessions for cervical cancer, and how long does each take

Numbers vary between centers, so treat these as typical shapes rather than promises. The NHS describes the external beam part of treatment as usually given five days a week for around five weeks. Brachytherapy then follows, sometimes starting in the final week of external beam and continuing for one to two weeks afterward.

High-dose-rate (HDR) brachytherapy, the form used in most modern units, is given as a series of separate insertions rather than one long one. The Mayo Clinic describes HDR as short treatments of minutes at a time, delivered over days or weeks, with the person going home between sessions in many cases. In cervical cancer practice this commonly means a small number of insertions, frequently somewhere between two and five, spaced a few days apart or twice weekly. Some units give two treatments during one insertion separated by several hours, which reduces the number of anesthetics.

Each session breaks down roughly like this: an hour or so of preparation and anesthesia, thirty minutes or more for applicator placement, one to two hours of imaging and planning, a treatment delivery of about five to twenty minutes, then removal and recovery. Half a day is a realistic expectation; a full day is not unusual at centers that give two fractions per insertion.

Why the fuss about schedule? Radiation oncologists try to complete the entire course, external and internal, without avoidable gaps, because tumor cells can repopulate during long pauses. This is why brachytherapy dates are often booked before external beam even begins, and why a missed session is rescheduled quickly rather than dropped. If your center proposes a different number of insertions from a friend’s, that reflects its dose-per-session approach, not a lesser plan. The total plan is what the team calculates, and that decision belongs to them.

HDR, LDR and PDR brachytherapy compared

Three dose-rate approaches exist, and the letters matter mainly for how long the applicator stays in and whether you go home. High-dose-rate (HDR) uses a strong source that delivers treatment in minutes. Low-dose-rate (LDR) uses a weaker source left in for a day or two. Pulsed-dose-rate (PDR) mimics LDR by delivering a short pulse every hour from an afterloader over a day or more.

Feature	HDR	PDR	LDR
Time source is active per session	Minutes	Short pulses hourly across 1–2 days	Continuous over 1–3 days
Applicator stays in	Hours	1–2 days	1–3 days
Hospital stay	Often same-day discharge	Inpatient, shielded room	Inpatient, shielded room
Number of insertions	Several, days apart	Usually one or two	Usually one or two
Staff contact during treatment	Unrestricted between fractions	Limited while source active	Limited while source active
Current use	Most common worldwide	Selected centers	Increasingly uncommon

The Mayo Clinic and Cleveland Clinic both describe HDR as the dominant approach today: the outpatient pattern, the ability to re-plan with each insertion and the absence of prolonged bed rest all favor it. LDR and PDR require staying in a shielded room with visitors limited while the source is active, and days of lying flat, which raises the risk of blood clots. Their advantage is a single anesthetic.

None of the three is ‘stronger.’ Physicists convert between dose rates so the biological effect on tumor and healthy tissue is intended to be comparable. What differs is your day: several shorter visits with HDR versus one long stay with LDR or PDR. Which your center uses depends on its equipment and expertise, and the treating team will explain why their approach suits your situation.

The days and weeks after: what recovery usually looks like

The first evening after an HDR session tends to feel like a heavy period combined with a long car journey. Cramping is common and usually eases within a day or two. Light bleeding or brownish discharge from the cervix, irritated by the applicator and the packing, can continue for several days. Passing urine may sting for a day because of the catheter. Fatigue often peaks the day after, partly from the anesthesia and partly from the cumulative weeks of external radiation already behind you.

Between sessions most women are up and about, and many continue working part-time or managing a household, though the Mayo Clinic notes that tiredness from radiation accumulates and can last weeks after the course ends. Diarrhea and bowel urgency, mostly from the external beam phase, frequently continue through the brachytherapy weeks and then settle over the following month or two. Nausea, if present, is usually a legacy of chemotherapy and fades once that stops.

Once the final applicator comes out, an odd flatness often follows. After weeks of daily appointments, the sudden silence can feel unsettling, and this is a normal reaction rather than a sign anything is wrong. Expect a review appointment within a few weeks to check on symptoms, and a scan some months later to assess how the tumor has responded; radiation continues to work on cancer cells for weeks after delivery, so imaging too soon can mislead.

Two practical instructions usually arrive at discharge. The first is about vaginal dilators, discussed in the long-term section below, which most teams start a few weeks after treatment ends. The second concerns sexual activity and bathing, where advice varies by unit and depends on bleeding and soreness. Follow your own team’s timeline rather than a general one, and write down who to call after hours before you leave the department.

Cervical cancer brachytherapy side effects in the short term

Short-term side effects of pelvic radiation are grouped by the organ that sits in the beam, and brachytherapy adds a few of its own related to the applicator. MedlinePlus and the NHS describe the common early effects of radiation to the pelvis, and most begin during external beam and overlap with the brachytherapy weeks.

• Bowel: loose stools, urgency, cramping and sometimes mucus or a little blood from an irritated rectum. Small, low-fiber meals often help; your team may suggest anti-diarrheal measures.
• Bladder: frequency, urgency and burning, resembling a urinary infection. Because a true infection can look identical, teams often test the urine before assuming it is radiation.
• Vagina and cervix: soreness, discharge that may be watery or blood-tinged, and light bleeding for a few days after each insertion.
• Whole body: fatigue that builds over the course, and low blood counts if chemotherapy is part of the plan.

Applicator-specific effects are usually mild and brief: a small tear or graze at the vaginal entrance, bruising if interstitial needles were used, and back or hip stiffness from hours of lying flat. Anesthesia adds a sore throat if a breathing tube was used, or a headache in a small proportion of people after a spinal.

Skin reactions, so familiar from breast or head and neck radiation, are less prominent in cervical treatment because the external beams enter through the abdomen and buttocks and the internal source barely reaches the skin. Some redness or darkening in the groin folds can still occur.

Most early effects reach their worst in the last week of treatment or the fortnight after and then improve steadily. What they should not do is worsen sharply, involve fever, or involve heavy bleeding; those patterns belong in the ‘when to call’ section, not in the list of expected nuisances.

What are the long-term side effects of cervical cancer brachytherapy?

Late effects appear months to years after treatment and come from scarring, called fibrosis, and from damage to small blood vessels in tissues that received significant radiation. The NHS and Mayo Clinic describe the main groups, and honest counseling before treatment means naming them plainly.

Vaginal narrowing and dryness. Radiation can make the vaginal walls shorter, narrower and less elastic, a change called vaginal stenosis. This can make sex and even routine pelvic examinations uncomfortable. Teams commonly recommend vaginal dilators, smooth tapered tubes used regularly from a few weeks after treatment, to keep the vagina open, along with water-based moisturizers. Evidence for dilators is largely observational and expert-consensus based, but it is the standard recommendation.

Menopause and fertility. External beam radiation to the pelvis stops the ovaries functioning in most premenopausal women, bringing menopause on abruptly, and the whole radiation program, not brachytherapy alone, ends the possibility of carrying a pregnancy. Discussions about egg or embryo freezing and about moving ovaries out of the field belong before treatment begins.

Bowel and bladder changes. A minority of women develop lasting bowel urgency, frequency or intermittent rectal bleeding from fragile vessels (radiation proctitis), or a smaller, more irritable bladder with occasional blood in the urine. Most cases are mild; a small proportion need specialist treatment.

Fistula. Uncommonly, an abnormal channel can form between the vagina and the rectum or bladder, causing leakage of stool or urine through the vagina. It usually requires surgical repair and is one of the reasons planning protects those organs so carefully.

Bone and lymphatic effects. Pelvic bones can weaken, leading to insufficiency fractures that cause hip or lower back pain, and leg swelling (lymphedema) can occur if lymph node areas were treated or removed.

Frequencies for each of these depend on stage, dose and technique, and your own team can give figures relevant to your plan.

What are the disadvantages of brachytherapy? Risks and alternatives

Every treatment carries trade-offs, and brachytherapy’s are mostly practical rather than biological. It is invasive: an applicator must be placed inside the body, which means anesthesia, a catheter, packing and hours of immobility, repeated several times. Anesthesia itself brings small risks, higher in women with heart or lung disease or significant obesity, and the anesthetic team assesses these before each insertion.

Placement can cause injury. The tandem occasionally perforates the wall of a uterus softened by tumor; teams check for this on imaging and, if it happens, usually withdraw and reposition, sometimes postponing that session. Bleeding from a friable cervix can be brisk during placement and is controlled with packing. Infection after insertion is uncommon but possible.

The organs closest to the source carry the long-term risk described above. Careful image-guided planning has reduced serious bowel and bladder injury, but the very steep dose gradient that protects those organs also means a small shift in the applicator matters, which is why the planning step cannot be rushed.

There are logistical disadvantages too. Brachytherapy needs specialized equipment and a team of radiation oncologists, physicists, anesthetists and nurses working together on the same afternoon. Not every radiation department offers it, so some women are referred to a different unit for this phase, which adds travel and coordination to an already demanding schedule.

What are the alternatives? For early-stage disease, surgery is the main alternative and is often preferred. For locally advanced disease, the principal alternative when brachytherapy cannot be delivered is an external beam boost, delivered with highly shaped techniques such as stereotactic radiation. Guideline bodies regard this as a compromise rather than an equivalent, because external beams cannot match the concentration of an internal source without exposing surrounding organs. Systemic treatment alone is reserved for disease that has spread widely. Which path suits you is a decision for your treating team, who will weigh anatomy, fitness and stage together.

What people often get wrong about brachytherapy

‘I will be radioactive afterward.’ With HDR, the source retracts fully into its shielded machine after each treatment; nothing stays in your body and you pose no radiation risk to children, pregnant relatives or pets. The Mayo Clinic makes this point explicitly. Only permanent seed implants, used for some prostate cancers and not for the cervix, leave a source in place.

‘Internal radiation is an old-fashioned technique.’ The principle is a century old; the practice is not. Current cervical brachytherapy is planned on MRI or CT for each insertion, with computer-optimized dwell times and independent checks. The delivery method has changed more in the past two decades than external beam has.

‘If the tumor has shrunk a lot, I can skip it.’ Shrinkage during external beam is expected and welcome, but microscopic disease remains in the cervix in most cases, and the internal boost is designed to address exactly that. Omitting brachytherapy is associated with poorer outcomes in national datasets, which is why guidelines treat it as a core component rather than a bonus for stubborn tumors.

‘Brachytherapy is what makes you infertile.’ Pelvic external beam radiation, delivered to the whole pelvis including the ovaries, is the main driver of ovarian failure and uterine damage. Brachytherapy adds to the uterine dose, but removing it would not preserve fertility. Fertility planning conversations need to happen before the first external beam session.

‘The pain lasts for weeks.’ Discomfort is concentrated in the hours the applicator is in place and the day or two afterward. Lingering symptoms through the treatment weeks are usually bowel and bladder effects from external beam, not applicator pain.

‘More sessions means my cancer is worse.’ Session number reflects the center’s dose-per-fraction approach and equipment, not prognosis. Two centers can reach an equivalent plan with different numbers of insertions.

Questions to ask your care team about brachytherapy for cervical cancer

Consultations run short and the vocabulary is unfamiliar, so a written list helps. These are the questions that, in practice, change how the treatment weeks feel, and asking them signals that you want to be a partner in the plan rather than a passenger.

• Which type of brachytherapy will I have, high-dose-rate or another approach, and will I go home the same day?
• How many insertions do you plan, how far apart, and roughly how long will each day take from arrival to leaving?
• What anesthesia will be used for placement, and what pain relief will be available while the applicator is in?
• Will you use MRI, CT or both for planning, and will the plan be redesigned at each session?
• Do you expect to use an intracavitary applicator alone or add interstitial needles, and what would prompt a change?
• What bowel and bladder preparation do you want on the day, and should I stop or continue any of my regular medicines beforehand?
• Which symptoms afterward are expected and which should prompt an immediate call, and what is the after-hours number?
• When should I start using vaginal dilators, how often, and who will teach me?
• How will this treatment affect my hormones, and who will manage menopausal symptoms if they start?
• When will my first follow-up scan be, and who coordinates my care once radiation finishes?

Two follow-up questions are worth keeping for the second conversation, once the plan has settled. First: ‘If the applicator does not fit or the uterus is perforated, what is plan B?’ Every unit has one, and hearing it in advance removes a common source of panic on the day. Second: ‘Who is the one person I contact if something feels wrong between sessions?’ Radiation, medical oncology and nursing teams share care during chemoradiation, and knowing the single door to knock on saves time when you are tired and worried.

Bring someone with you if you can, and ask whether the department has a written pathway leaflet; most do, and reading it the night before the first insertion is calmer than absorbing it in the anesthetic room.

When to call your doctor during and after brachytherapy

Most of what you will feel during the brachytherapy weeks is uncomfortable but expected. A short list of signs is different, and teams would far rather hear about them at midnight than read about them at the next appointment.

Call the same day, or go to an emergency department if you cannot reach your team, for any of the following:

• A temperature of 100.4°F (38°C) or higher, shaking chills, or feeling suddenly unwell, especially if you are also receiving chemotherapy, since low white cell counts can turn an infection dangerous within hours.
• Heavy vaginal bleeding: soaking a pad in an hour or passing large clots. Light spotting for a few days is normal; a flow that fills pads is not.
• Severe or worsening abdominal or pelvic pain that is not relieved by the pain relief you were given, or a rigid, swollen abdomen.
• Persistent vomiting, or inability to keep fluids down for more than a day.
• Passing urine less than usual, very dark urine, dizziness on standing, or confusion, which can signal dehydration or a urinary blockage.
• Stool or urine leaking from the vagina, or a foul-smelling discharge, which needs prompt assessment for infection or fistula.
• A swollen, painful calf, sudden breathlessness or chest pain, which can indicate a blood clot, a recognized risk after anesthesia, bed rest and cancer itself.

In the months and years after treatment, new symptoms also deserve a call rather than a wait: fresh rectal bleeding, blood in the urine, new hip or lower back pain that makes walking difficult, or leg swelling on one side. These may be late radiation effects, may be unrelated, and occasionally signal recurrence. Only assessment can tell them apart, and your treating team is the right first contact.

Keep the after-hours number saved in your phone under a name you will recognize when tired. Nurses on those lines are used to these calls; there is no threshold of severity you must reach before dialing.

Frequently asked questions

Is brachytherapy for cervical cancer painful?

The radiation itself is painless, and the applicator is placed under anesthesia or sedation so insertion is not felt. Discomfort comes afterward while the applicator stays in: deep cramping like a heavy period, pelvic pressure from the packing, and the urge to urinate from the catheter. Pain relief is given during this time. Removal takes a minute or two, and cramping usually eases within a day or two.

How many brachytherapy sessions for cervical cancer are typical?

Most centers using high-dose-rate treatment plan a small number of separate insertions, commonly between two and five, spaced days apart during or after the external beam phase. Some units give two treatments in one insertion several hours apart. The exact number reflects the center’s dose-per-session approach rather than how serious the cancer is, and your treating team sets the schedule.

What are the disadvantages of brachytherapy?

It is invasive and needs repeated anesthesia, a catheter, packing and hours of lying still, which is tiring and uncomfortable. Placement can occasionally perforate the uterus or cause bleeding, and the bladder and rectum lie close enough to the source to carry a small long-term injury risk. It also requires specialized equipment and staff, so some women travel to a different unit for this phase.

What are the long-term side effects of cervical cancer brachytherapy?

The most common late effect is vaginal narrowing and dryness from scarring, which dilators and moisturizers help manage. Others include lasting bowel urgency or intermittent rectal bleeding, a smaller irritable bladder, pelvic bone weakening, and rarely a fistula between the vagina and bowel or bladder. Menopause and infertility result from the whole pelvic radiation program, mainly the external beam part.

Am I radioactive after internal radiation for cervical cancer?

Not with high-dose-rate brachytherapy. The source travels out of a shielded machine into the applicator, delivers treatment for minutes, then retracts completely before the applicator is removed. You can be around children and pregnant relatives immediately. Only permanent seed implants, used for some other cancers and not the cervix, leave a source in the body.

Will I be awake during cervical brachytherapy?

Applicator placement is done under general anesthesia, spinal anesthesia or sedation, so you will be asleep or numb for that part. Most people are awake, resting on a bed, during imaging, planning and the actual treatment, which is painless. During the few minutes the source is active, staff leave the shielded room but watch you on camera and can talk through an intercom.

Can I go home the same day after a brachytherapy session?

With high-dose-rate treatment, same-day discharge is common once the anesthesia has worn off, you have passed urine after the catheter is removed and pain is controlled. You will need someone to take you home. Low-dose-rate or pulsed-dose-rate approaches, less widely used now, require staying in a shielded hospital room for one to three days while the source is active.

Why is MRI used for cervical cancer brachytherapy planning?

MRI shows the soft tissue of the cervix, any remaining tumor and the neighboring bowel and bladder far more clearly than CT. Scanning with the applicator in place lets the team outline exactly what needs full treatment and what must be protected on that particular day. Because the tumor shrinks and the applicator sits differently each time, many centers re-image and re-plan at every insertion.

What happens if the brachytherapy applicator does not fit?

Teams have alternatives ready. A narrow vagina or destroyed cervical canal may call for a smaller applicator, a sleeve placed in the cervix, or interstitial needles inserted directly into tissue through a template. If the uterus is perforated during placement, the tandem is repositioned or the session is postponed briefly. An external beam boost is a last resort when no internal approach is possible.

When can I have sex after cervical cancer brachytherapy side effects settle?

Advice varies by unit and depends on bleeding and soreness, so follow your own team’s timeline. Many teams suggest waiting until acute soreness and discharge have settled, often a few weeks after the final session, and starting dilators around the same time to prevent narrowing. Water-based lubricant, gentle positions and open conversation with a partner help; persistent pain deserves a review, not endurance.

References

• NHS: Cervical cancer, Treatment
• MedlinePlus: Cervical Cancer

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.